OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2687$501.0057

CVS Bay Area Inc

Business Support ServicesVerified

CVS Bay Area Inc has a liquidity position that is below the industry median, with a current ratio of 0.86 and a debt-to-equity ratio of 1.83, indicating a higher reliance on debt financing. The company's price-to-book ratio of 0.79 suggests that the market values the company at a discount to its book value, which may reflect concerns about its profitability or future cash flows. The company's profitability is significantly below the industry median, with a negative return on equity of -36.47% and a negative return on assets of -10.99%. These metrics indicate that the company is not generating returns that exceed its cost of capital, which is a red flag for investors. The operating margin is also negative, with an operating loss of 485.58 million JPY, further highlighting the company's financial distress. CVS Bay Area Inc's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases the company's exposure to sector-specific risks and limits its ability to offset losses in one area with gains in another. The company's growth trajectory is negative, with a free cash flow of -1.47 billion JPY and a capital expenditure of -523.31 million JPY. These figures suggest that the company is not only failing to generate positive cash flows but is also investing in capital expenditures without a clear path to profitability. The outlook for the current fiscal year indicates a continuation of this trend, with no significant improvement expected. The risk assessment for CVS Bay Area Inc highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could lead to liquidity constraints. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential in the near term. Recent events, including the latest financial filings and transcripts, indicate that the company is facing significant financial challenges. The negative earnings per share of -230.91 JPY and the negative operating income of 485.58 million JPY are clear indicators of the company's financial distress. These figures are consistent with the company's overall financial performance and suggest that the company is not currently in a position to sustain profitability.

30-day price · 2687-9.00 (-1.8%)
Low$481.00High$525.00Close$489.00As of21 May, 00:00 UTC
Profile
CompanyCVS Bay Area Inc
Ticker2687.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. CVS Bay Area Inc operates in the Business Support Services industry, providing industrial and commercial services, primarily generating revenue through service contracts and operational support.

Classification. CVS Bay Area Inc is classified under the industry Business Support Services within the Industrial & Commercial Services business sector, with a classification confidence of 0.92.

CVS Bay Area Inc has a liquidity position that is below the industry median, with a current ratio of 0.86 and a debt-to-equity ratio of 1.83, indicating a higher reliance on debt financing. The company's price-to-book ratio of 0.79 suggests that the market values the company at a discount to its book value, which may reflect concerns about its profitability or future cash flows. The company's profitability is significantly below the industry median, with a negative return on equity of -36.47% and a negative return on assets of -10.99%. These metrics indicate that the company is not generating returns that exceed its cost of capital, which is a red flag for investors. The operating margin is also negative, with an operating loss of 485.58 million JPY, further highlighting the company's financial distress. CVS Bay Area Inc's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases the company's exposure to sector-specific risks and limits its ability to offset losses in one area with gains in another. The company's growth trajectory is negative, with a free cash flow of -1.47 billion JPY and a capital expenditure of -523.31 million JPY. These figures suggest that the company is not only failing to generate positive cash flows but is also investing in capital expenditures without a clear path to profitability. The outlook for the current fiscal year indicates a continuation of this trend, with no significant improvement expected. The risk assessment for CVS Bay Area Inc highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could lead to liquidity constraints. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential in the near term. Recent events, including the latest financial filings and transcripts, indicate that the company is facing significant financial challenges. The negative earnings per share of -230.91 JPY and the negative operating income of 485.58 million JPY are clear indicators of the company's financial distress. These figures are consistent with the company's overall financial performance and suggest that the company is not currently in a position to sustain profitability.
Key takeaways
  • CVS Bay Area Inc is operating at a loss, with a negative return on equity and return on assets.
  • The company's liquidity position is weak, with a current ratio below 1 and a high debt-to-equity ratio.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • The company's free cash flow is negative, and capital expenditures are not generating positive returns.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$7.90B
Gross profit$3.79B
Operating income-$485.6M
Net income-$1.14B
R&D
SG&A
D&A
SBC
Operating cash flow$315.3M
CapEx-$523.3M
Free cash flow-$1.47B
Total assets$10.37B
Total liabilities$7.24B
Total equity$3.13B
Cash & equivalents$1.89B
Long-term debt$5.72B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$7.90B-$485.6M-$1.14B-$1.47B
FY-1$7.82B$423.3M$1.12B-$317.3M
FY-2$7.52B$492.8M$697.6M-$358.9M
FY-3$6.93B$30.0M-$13.5M$43.7M
FY-4$7.21B-$777.1M-$831.5M-$801.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$10.37B$3.13B$1.89B
FY-1$11.27B$4.38B$1.78B
FY-2$10.28B$3.36B$1.89B
FY-3$8.68B$2.74B$1.77B
FY-4$9.41B$2.83B$1.73B
PeriodOCFCapExFCFSBC
FY0$315.3M-$523.3M-$1.47B
FY-1$410.5M-$1.49B-$317.3M
FY-2$481.9M-$1.13B-$358.9M
FY-3-$172.5M-$28.5M$43.7M
FY-4-$351.4M-$74.0M-$801.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.89B-$599.6M-$1.11B
FQ-1$2.03B$89.5M$38.6M
FQ-2$1.90B-$19.8M-$112.3M
FQ-3$2.08B$44.4M$46.1M
FQ-4$1.86B-$27.8M$203.7M
FQ-5$2.06B$168.8M$103.5M
FQ-6$1.90B$89.0M$659.5M
FQ-7$2.00B$193.3M$156.4M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$10.37B$3.13B$1.89B
FQ-1$11.85B$4.24B$2.04B
FQ-2$11.54B$4.25B$1.86B
FQ-3$11.79B$4.36B$1.93B
FQ-4$11.27B$4.38B$1.78B
FQ-5$10.98B$4.18B$2.00B
FQ-6$11.04B$4.12B$2.45B
FQ-7$10.88B$3.47B$2.09B
PeriodOCFCapExFCFSBC
FQ0$315.3M-$523.3M
FQ-1
FQ-2$262.1M-$574.8M
FQ-3
FQ-4$410.5M-$1.49B
FQ-5
FQ-6$350.2M-$760.8M
FQ-7
Valuation
Market price$501.00
Market cap$2.47B
Enterprise value$6.31B
P/E
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income
EV/OCF20.0
P/B0.8
P/Tangible book0.8
Tangible book$3.13B
Net cash-$3.84B
Current ratio0.9
Debt/Equity1.8
ROA-11.0%
ROE-36.5%
Cash conversion-28.0%
CapEx/Revenue-6.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Business Support Services · cohort 3 companies
Metric2687Activity
Op margin-6.1%12.9% medp25 10.1% · p75 16.8%bottom quartile
Net margin-14.4%8.1% medp25 5.0% · p75 12.7%bottom quartile
Gross margin48.0%39.4% medp25 37.7% · p75 41.1%top quartile
R&D / revenue12.0% medp25 12.0% · p75 12.0%
CapEx / revenue-6.6%1.5% medp25 1.1% · p75 2.7%bottom quartile
Debt / equity183.0%85.6% medp25 75.5% · p75 407.3%above median
Observations
IR observations
Last actual EPS-230.91 JPY
Last actual revenue7,902,050,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 03:20 UTC#d5b69b3d
Market quoteclose JPY 501.00 · shares 0.00B diluted
no public URL
2026-05-02 03:20 UTC#f7dfe93a
Source: analysis-pipeline (hybrid)Generated: 2026-05-02 03:21 UTCJob: cb695276